Obviously I couldn't be bothered opening your links, but thank you backing up my rhetorical question " Who needs training to learn that you don't squirt volatile substances down your jap's eye?"
Bwaahahahaha! You're an absolute joke and you can't even see it!
"Not if “patient training” included making sure the participants didn’t rub the alcohol gel into the urethral meatus and many other study controls to try reduce the 'burning'. "
That's a massive "if" that booth slid in there. In fact it's a nonsense line he's made up. Who needs training to learn that you don't squirt volatile substances down your jap's eye?
I also notice that he's put apostrophes around 'burning'. Clearly an acknowledgement that 'burning' is a non-issue, especially compared to his favourite that he keeps mentioning - Zestra. "In the clinical studies, the only observed adverse event of Zestra® was genital burning (14%) subjects". Compare that to a figure of 0.4% experienced by women after contact with Eroxon.
That's 1 in 7 compared to 1 in 250.
As I said, a total non-issue.
I see booth was promoting Zestra for women earlier on this morning, which is a herbal product supposed to turn them on a bit, they call it the Zestra Rush. And the basher then tries to call Eroxon (a clinically proven remedy for ED) snake oil! I'd like to say you couldn't make it up, but booth does make it up, constantly.
Luckily, "only" one in seven women suffered bush fires with Zestra- "In the clinical studies, the only observed adverse event of Zestra® was genital burning (14%) subjects".
I wonder what the stock bashers will be promoting next? They're going from one ridiculous thing to another. Things must be getting desperate in the boothy bedroom.
A good day today. Not only did I make the basher backtrack on on of his lies, I also turned him into my shouty biatch! Come on booth, you're my biatch now!
Bashers inc have to make a decision now. Do they complain about me calling booth my biatch, with the risk that the whole "odd" thread will be cancelled, or do they let it lie? I can imagine the emails flying! On balance, considering my first sentence, they'll put in a report. Sorry to anyone who valued their own contributions, but just think how many bashing posts also went down the drain!
Firstly, you agree that it's going through the skin, although you initially said "Without a drug nothing is delivered through the skin". So you're backtracking on your initial claim. Then you declare that it's only delivering water. It's actually delivering itself, which is a proven vasodilator. To say that it's only delivering water would indicate that you know exactly what is in Dermasys, but you don't.
"Each gel is uniquely formulated using the DermaSys® platform with penetration and permeation enhancer components tailored for each product to suit the specific therapeutic indication and desired speed of onset and duration of action. Such targeted delivery offers an optimised profile in terms of dose, onset time and duration of effect as well as an improved safety profile reducing the risk of side effects. "
You've no idea what the exact Dermasys formulation for MED3000 is, so don't pretend you do. You've also no idea of the volatility of the VOCs so you cannot claim that they all evaporate before penetrating the skin, so don't make wild claims as if you do know.
And don't go rubbing any fly killer or windscreen wash on you percy just to prove that you're right. Not that you would because you know perfectly well that all your comments are inflated rubbish designed to bash the stock, and have minimal connection to the truth.
Dermasys.
Futura’s unique technology, expertise and know how, enables targeted and rapid delivery of active pharmaceutical ingredients (API) and Generally Recognized As Safe (GRAS) pharmaceutical excipients onto and through the skin to the required site of action with a high level of safety.
Are you saying that if Dermasys is on its own, it loses the ability to travel through the skin? It is known to be transdermic and also have a vasodilatory effect, are you saying that those properties, for which Dermasys is a patented and proven medium, do not occur unless it's carrying something? I think you need to bone up (d'ya geddit? Bone up! What Eroxon does!) on Dermasys and MED3000, rather than just concentrating on the evaporative properties. It makes you look like a half-witted stock basher, who never describes the whole picture. Start here:
https://www.futuramedical.com/what-we-do/our-technology/
Futura’s unique transdermal technology DermaSys® enables targeted and rapid delivery of clinically proven effective medical treatments through the skin. If it's going through the skin, where does it end up rather than in the body?
The difference between things containing alcohol and water; are these things the same or even similar?
Beer - insect spray - bread - fruit juice - yoghurt- hand gel - mouthwash - windscreen washer fluid - vanilla extract - the list is endless. To take the basher's lies at face value, all these things could claim equivalance with Eroxon, given that they're "the same", in his explanation.
For medical devices that are composed of several substances or represent a combination of substances and are absorbed or dissolved in the human body, the same substances must also be used to demonstrate equivalence. Even if these products do not constitute medicinal products, the MDCG 2020-5 points out that compliance with the relevant requirements of Annex 1 of Directive 2001/83/EC must nevertheless be taken into account in order to claim biological equivalence within the scope of the MDR.
Does your average lubricant with menthol contain Dermasys, a patented drug delivery technology platform? Does the menthol gel manufacturer have an ongoing contract with Futura to licence production of Dermasys?
A "stock basher" is someone that will constantly "bash" a company in the hopes of inspiring a lower share price.
In the vast majority of cases, a "stock basher" has a short position in the stock that they are bashing, which means that a lowering of the share price will lead to financial gains for the "basher".
The rarer case of a "stock basher" is a former shareholder or former employee of the company who is seeking some sort of payback.
Personally, I suspect option 2. Have you noticed, when he claims to be a shareholder, it's wording like this: "I have been a long term holder..." or words to that effect, rather than a straight "I am a long term holder". (This is from memory, I know you'll excuse me for not spending two weeks trawling through all his repetitive rubbish looking for something to copy/paste)' Maybe he actually was a LTH but sold out after P3 and lost everything. Kept quiet for a bit but then the SP started creeping up and now he's beside himself with spite, and then decided to seek "some sort of payback". Of course, the other option a disgruntled ex employee. No names, no pack drill, but there was an ex-senior board member who turned up at the last shareholders meeting intent on disrupting it with constant questions. Sound familiar?
Now he's going on about phase 2 and MED2005. Totally irrelevant to Eroxon, and so is all his side-tracking about STIs.
As Investopedia tells us, "A stock basher is a person engaging in an illegal type of market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that stock."
Old hands here know that booth is a stock basher, any newbies coming to this board who may not have realised, just read his nonsense which he repeats ad-nauseum. Go to ADVFN if you want to see how his disruption can affect a share chat platform.
The only surprise is that the moderators haven't banned him and his other aliases yet.
Here's a very informative article about strawman arguments which describe's booths underhand tactics to a T, and how to counter them:
https://effectiviology.com/straw-man-arguments-recognize-counter-use/
More lies and nonsense from booth. "...and lubricants can NOW submit to be reclassified from class 2a to 2b based on the same equivalence and make the same claim that mechanical stimulation with a gel helps men with ED"
Other gel manufacturers cannot claim equivalence until after Eroxon has successfully launched and proven to work, i.e. fulfilled the performance requirements. Not only that, the hand gel manufacturer would have to have a current valid contract between them and Futura allowing ongoing access to the technical documentation in accordance with Article 61 (5) of the MDR.
So all booth's spurious and nonsensical arguments are purely conjecture about what may happen in the future, after the successful launch of Eroxon.
Booth is an embarrassment, isn't he? Trying so hard to make his arguments appear relevant, and failing dismally. He should just give up, unless he's being paid, of course. His heart is clearly not in it anymore, it's like he's just going through the motions, churning out the same old nonsense that everyone can see straight through. Sightwatcher has already given up on him, niknak will soon follow, especially as he's not even being paid for his support!